Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticobasal degeneration: selected developments.

Anthony E Lang1

  • 1Department of Medicine (Neurology), University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada. lang@uhnres.utoronto.ca

Movement Disorders : Official Journal of the Movement Disorder Society
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

Gelastic Cataplexy in Niemann Pick Type C.

Movement disorders clinical practice·2019
Same author

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019
Same author

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019
Same author

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2019
Same author

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Parkinsonism & related disorders·2019
Same journal

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Reply to Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Corticobasal degeneration (CBD) is a tauopathy with diverse clinical presentations. Understanding its relationship with progressive supranuclear palsy (PSP) is crucial for potential treatments.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases

Background:

  • Corticobasal degeneration (CBD) is classified as a four-repeat tauopathy.
  • Diagnosis relies on identifying tau-immunoreactive lesions in neurons and glia.
  • CBD presents with varied clinical phenotypes and can be associated with other conditions causing corticobasal syndrome.

Purpose of the Study:

  • To review the classification, clinical phenotypes, and diagnostic challenges of Corticobasal degeneration (CBD).
  • To explore the relationship between CBD and progressive supranuclear palsy (PSP).

Main Methods:

  • Selective literature review focusing on Corticobasal degeneration (CBD).

Main Results:

  • Diagnostic inaccuracy in previous CBD cases is a significant concern.

Related Experiment Videos

  • Substantial clinical, pathological, and genetic overlap exists between CBD and PSP.
  • The etiological and pathogenetic links between CBD and PSP remain unclear.

    • Conclusions:

    • CBD and PSP may represent different phenotypes of a single disease process.
    • Distinct or related, treatments for one condition might benefit the other.